MicroRNAs in Fibrosis: Opportunities and Challenges

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2016 Jan 15

PMID 26762516

Citations 86

Authors

Steven OReilly

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that mediate mRNA cleavage, translational repression or mRNA destabilisation and are around 22-25 nucleotides in length via partial complementary binding to the 3' untranslated region in target transcripts. They are master regulators of gene expression. Fibrosis is an important cause of morbidity and mortality in the world, and there are currently no accepted treatments for fibrosis. Many novel miRNAs are now associated with fibrosis, both organ-specific and systemic, as in the prototypical fibrotic disease systemic sclerosis. Recently, the targets of these altered miRNAs have been validated and defined new biochemical pathways. Dysregulated miRNAs are amenable to therapeutic modulation. This review will examine the role of miRNAs in fibrosis and the opportunities and challenges of targeting them.

Citing Articles

The Role of MicroRNAs in Liver Functioning: from Biogenesis to Therapeutic Approaches (Review).

Kozlov D, Rodimova S, Kuznetsova D Sovrem Tekhnologii Med. 2025; 15(5):54-79.

PMID: 39967915 PMC: 11832066. DOI: 10.17691/stm2023.15.5.06.

Targeting extracellular matrix stiffness for cancer therapy.

Feng X, Cao F, Wu X, Xie W, Wang P, Jiang H Front Immunol. 2024; 15():1467602.

PMID: 39697341 PMC: 11653020. DOI: 10.3389/fimmu.2024.1467602.

Identification and characterization of host miRNAs that target the mouse mammary tumour virus (MMTV) genome.

Gull B, Ahmad W, Baby J, Panicker N, Khader T, Rizvi T Open Biol. 2024; 14(12):240203.

PMID: 39657819 PMC: 11631425. DOI: 10.1098/rsob.240203.

The Regulation of MicroRNA-21 by Interleukin-6 and Its Role in the Development of Fibrosis in Endometriotic Lesions.

Ochoa Bernal M, Song Y, Joshi N, Burns G, Paul E, Vegter E Int J Mol Sci. 2024; 25(16).

PMID: 39201680 PMC: 11354763. DOI: 10.3390/ijms25168994.

CircRNA and lncRNA-associated competing endogenous RNA networks in medulloblastoma: a scoping review.

Nejadi Orang F, Shadbad M Cancer Cell Int. 2024; 24(1):248.

PMID: 39010056 PMC: 11251335. DOI: 10.1186/s12935-024-03427-w.

References

Roncarati R, Viviani Anselmi C, Losi M, Papa L, Cavarretta E, da Costa Martins P . Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013; 63(9):920-7. DOI: 10.1016/j.jacc.2013.09.041. View

Chen H, Zhong X, Huang X, Meng X, You Y, Chung A . MicroRNA-29b inhibits diabetic nephropathy in db/db mice. Mol Ther. 2014; 22(4):842-53. PMC: 3982502. DOI: 10.1038/mt.2013.235. View

OReilly S, Ciechomska M, Cant R, van Laar J . Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem. 2014; 289(14):9952-60. PMC: 3975039. DOI: 10.1074/jbc.M113.545822. View

Charrier A, Chen R, Chen L, Kemper S, Hattori T, Takigawa M . Exosomes mediate intercellular transfer of pro-fibrogenic connective tissue growth factor (CCN2) between hepatic stellate cells, the principal fibrotic cells in the liver. Surgery. 2014; 156(3):548-55. PMC: 4150742. DOI: 10.1016/j.surg.2014.04.014. View

Montgomery R, Yu G, Latimer P, Stack C, Robinson K, Dalby C . MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol Med. 2014; 6(10):1347-56. PMC: 4287936. DOI: 10.15252/emmm.201303604. View

Ciechomska M, OReilly S, Suwara M, Bogunia-Kubik K, van Laar J . MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis. PLoS One. 2014; 9(12):e115596. PMC: 4280195. DOI: 10.1371/journal.pone.0115596. View

Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C . MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Liver Int. 2014; 35(4):1234-43. DOI: 10.1111/liv.12660. View

Pirola C, Fernandez Gianotti T, Castano G, Mallardi P, San Martino J, Gonzalez Lopez Ledesma M . Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut. 2014; 64(5):800-12. PMC: 4277726. DOI: 10.1136/gutjnl-2014-306996. View

Millar N, Gilchrist D, Akbar M, Reilly J, Kerr S, Campbell A . MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease. Nat Commun. 2015; 6:6774. PMC: 4403384. DOI: 10.1038/ncomms7774. View

10.

Knabel M, Ramachandran K, Karhadkar S, Hwang H, Creamer T, Chivukula R . Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice. PLoS One. 2015; 10(4):e0124411. PMC: 4414421. DOI: 10.1371/journal.pone.0124411. View

11.

Yu F, Guo Y, Chen B, Dong P, Zheng J . MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest. 2015; 95(7):781-9. DOI: 10.1038/labinvest.2015.58. View

12.

Petersen M, Wengel J . LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol. 2003; 21(2):74-81. DOI: 10.1016/S0167-7799(02)00038-0. View

13.

Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk G . Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 2003; 31(11):2705-16. PMC: 156727. DOI: 10.1093/nar/gkg393. View

14.

Hazra S, Xiong S, Wang J, Rippe R, Krishna V, Chatterjee K . Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem. 2004; 279(12):11392-401. DOI: 10.1074/jbc.M310284200. View

15.

Yamakage A, Kikuchi K, Smith E, LeRoy E, Trojanowska M . Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts. J Exp Med. 1992; 175(5):1227-34. PMC: 2119209. DOI: 10.1084/jem.175.5.1227. View

16.

Jopling C, Yi M, Lancaster A, Lemon S, Sarnow P . Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 2005; 309(5740):1577-81. DOI: 10.1126/science.1113329. View

17.

Esau C, Davis S, Murray S, Yu X, Pandey S, Pear M . miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006; 3(2):87-98. DOI: 10.1016/j.cmet.2006.01.005. View

18.

Wang X, Zhang Y, Kim H, Zhou Z, Feghali-Bostwick C, Liu F . Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med. 2006; 203(13):2895-906. PMC: 1850940. DOI: 10.1084/jem.20061536. View

19.

OConnell R, Taganov K, Boldin M, Cheng G, Baltimore D . MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A. 2007; 104(5):1604-9. PMC: 1780072. DOI: 10.1073/pnas.0610731104. View

20.

Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee J, Lotvall J . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-9. DOI: 10.1038/ncb1596. View